Document Detail


Dexamethasone suppression of IL-1 beta-induced cyclooxygenase 2 expression is not mediated by lipocortin-1 in A549 cells.
MedLine Citation:
PMID:  8048967     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A549 cells grown under serum free conditions do not express cyclooxygenase 2 (cox 2). However, addition of IL-1 beta results in the induction of cox 2 in a time and dose dependent manner; actinomycin D completely blocks this induction. Dexamethasone completely suppressed the induction of cox 2 only if present during the first 3.5h of IL-1 beta treatment but not if added after 3.5h. Treatment with a neutralising monoclonal antibody (1A, Biogen) specific to lipocortin-1 failed to reverse this inhibition by dexamethasone. However, using this same antibody we were able to reverse completely the effects of dexamethasone on the suppression of PGE2 release. These observations support the idea that glucocorticoids directly regulate cox 2 expression at the transcriptional level and this phenomenon is not mediated by lipocortin-1.
Authors:
S P Newman; R J Flower; J D Croxtall
Related Documents :
24069137 - High brain ammonia tolerance and down-regulation of na(+):k(+):2cl(-) cotransporter 1b ...
10212217 - Glucocorticoid induction of epithelial sodium channel expression in lung and renal epit...
25056347 - Expression of a novel stress-inducible protein, sestrin 2, in rat glomerular parietal e...
11673257 - Alteration of glutathione reductase expression in the female reproductive organs during...
11101627 - Fluorescence in situ hybridization of scarce leptin receptor mrna using the enzyme-labe...
8393767 - Multiple regulation of s14 gene expression during brown fat differentiation.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Biochemical and biophysical research communications     Volume:  202     ISSN:  0006-291X     ISO Abbreviation:  Biochem. Biophys. Res. Commun.     Publication Date:  1994 Jul 
Date Detail:
Created Date:  1994-09-01     Completed Date:  1994-09-01     Revised Date:  2010-08-25    
Medline Journal Info:
Nlm Unique ID:  0372516     Medline TA:  Biochem Biophys Res Commun     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  931-9     Citation Subset:  IM    
Affiliation:
Department of Biochemical Pharmacology, William Harvey Research Institute, Medical School of St. Batholomew's Hospital, London, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Annexins / immunology,  physiology
Antibodies, Monoclonal / pharmacology
Cell Line
Cycloheximide / pharmacology
Dactinomycin / pharmacology
Dexamethasone / pharmacology*
Dinoprostone / secretion
Epidermal Growth Factor / pharmacology
Gene Expression / drug effects*
Interleukin-1 / pharmacology*
Prostaglandin-Endoperoxide Synthases / biosynthesis,  genetics*
Grant Support
ID/Acronym/Agency:
//Wellcome Trust
Chemical
Reg. No./Substance:
0/Annexins; 0/Antibodies, Monoclonal; 0/Interleukin-1; 363-24-6/Dinoprostone; 50-02-2/Dexamethasone; 50-76-0/Dactinomycin; 62229-50-9/Epidermal Growth Factor; 66-81-9/Cycloheximide; EC 1.14.99.1/Prostaglandin-Endoperoxide Synthases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Therapeutic effects of imidazolineoxyl N-oxide against endotoxin shock through its direct nitric oxi...
Next Document:  A simple luminescence method for detecting lipid peroxidation and antioxidant activity in vitro.